R. E. Chaisson

1.3k total citations
31 papers, 820 citations indexed

About

R. E. Chaisson is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, R. E. Chaisson has authored 31 papers receiving a total of 820 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 14 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in R. E. Chaisson's work include Tuberculosis Research and Epidemiology (21 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers) and Pneumonia and Respiratory Infections (6 papers). R. E. Chaisson is often cited by papers focused on Tuberculosis Research and Epidemiology (21 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers) and Pneumonia and Respiratory Infections (6 papers). R. E. Chaisson collaborates with scholars based in United States, South Africa and Brazil. R. E. Chaisson's co-authors include Jonathan E. Golub, G W Comstock, Sarah Bur, Stephen J. Gange, Wendy Cronin, R. D. Moore, Jeanne Keruly, Kelly A. Gebo, Neil Martinson and Christopher J. Hoffmann and has published in prestigious journals such as Hepatology, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

R. E. Chaisson

30 papers receiving 783 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. E. Chaisson United States 15 594 496 185 103 45 31 820
Patricia García de Olalla Spain 18 514 0.9× 448 0.9× 214 1.2× 39 0.4× 49 1.1× 31 779
Andrea Tramarin Italy 17 461 0.8× 368 0.7× 79 0.4× 68 0.7× 69 1.5× 42 798
Helena Huerga France 19 668 1.1× 521 1.1× 139 0.8× 93 0.9× 176 3.9× 62 994
Mirjam I. Bakker Netherlands 20 793 1.3× 512 1.0× 238 1.3× 42 0.4× 87 1.9× 41 983
Frances Wallach United States 11 577 1.0× 315 0.6× 116 0.6× 28 0.3× 46 1.0× 25 845
Colin Menezes South Africa 15 516 0.9× 264 0.5× 247 1.3× 109 1.1× 153 3.4× 62 946
C. Lynn Besch United States 11 620 1.0× 359 0.7× 86 0.5× 23 0.2× 74 1.6× 19 817
P G Gopi India 18 883 1.5× 574 1.2× 296 1.6× 140 1.4× 53 1.2× 48 1.1k
Johann Cailhol France 13 337 0.6× 202 0.4× 147 0.8× 25 0.2× 59 1.3× 38 585
Saskia Janssen Netherlands 16 478 0.8× 326 0.7× 144 0.8× 52 0.5× 44 1.0× 35 729

Countries citing papers authored by R. E. Chaisson

Since Specialization
Citations

This map shows the geographic impact of R. E. Chaisson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. E. Chaisson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. E. Chaisson more than expected).

Fields of papers citing papers by R. E. Chaisson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. E. Chaisson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. E. Chaisson. The network helps show where R. E. Chaisson may publish in the future.

Co-authorship network of co-authors of R. E. Chaisson

This figure shows the co-authorship network connecting the top 25 collaborators of R. E. Chaisson. A scholar is included among the top collaborators of R. E. Chaisson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. E. Chaisson. R. E. Chaisson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lebina, Limakatso, Minja Milovanovic, R. E. Chaisson, et al.. (2015). Latent tuberculous infection in schoolchildren and contact tracing in Matlosana, North West Province, South Africa. The International Journal of Tuberculosis and Lung Disease. 19(11). 1290–1292. 6 indexed citations
2.
Chen, Sheng, Zhe Zhou, Ni Diao, et al.. (2015). MTBDRplus results correlate with treatment outcome in previously treated tuberculosis patients. The International Journal of Tuberculosis and Lung Disease. 19(3). 319–325. 4 indexed citations
3.
Martinson, Neil, Christopher J. Hoffmann, & R. E. Chaisson. (2011). Epidemiology of Tuberculosis and HIV: Recent Advances in Understanding and Responses. Proceedings of the American Thoracic Society. 8(3). 288–293. 50 indexed citations
4.
Adrian, Peter V., et al.. (2011). QuantiFERON®-TB Gold In-Tube for the detection of <I>Mycobacterium tuberculosis</I> infection in children with household tuberculosis contact. The International Journal of Tuberculosis and Lung Disease. 15(5). 628–634. 23 indexed citations
5.
Bishai, David, et al.. (2007). The cost-effectiveness of DOTS in urban Brazil.. PubMed. 11(1). 27–32. 16 indexed citations
6.
Cavalcante, Solange, et al.. (2007). Community DOT for tuberculosis in a Brazilian favela: comparison with a clinic model.. PubMed. 11(5). 544–9. 30 indexed citations
7.
Pacheco, Antônio Guilherme, et al.. (2006). Improvements in treatment success rates with directly observed therapy in Rio de Janeiro City.. PubMed. 10(6). 690–5. 11 indexed citations
8.
Golub, Jonathan E., Sarah Bur, Wendy Cronin, et al.. (2006). Delayed tuberculosis diagnosis and tuberculosis transmission.. PubMed. 10(1). 24–30. 188 indexed citations
9.
Teixeira, Eleny Guimarães, Dick Menzies, G W Comstock, et al.. (2005). Latent tuberculosis infection among undergraduate medical students in Rio de Janeiro State, Brazil.. PubMed. 9(8). 841–7. 42 indexed citations
10.
Sulkowski, Mark, Daniel Thomas, Sameer Mehta, R. E. Chaisson, & Raeanne C. Moore. (2003). 1125 Hepatotoxicity associated with the antiretroviral therapy (ART) containing protease inhibitors (PIS) with or without pharmacokinetic boosting by low-dose ritonavir (RTV). Hepatology. 38. 698–698. 2 indexed citations
11.
Chaisson, R. E., et al.. (2000). Tuberculosis and HIV/AIDS in South Africa- The deadly partnership. Southern African Journal of HIV Medicine. 1(2). 1 indexed citations
12.
Chaisson, R. E.. (2000). New developments in the treatment of latent tuberculosis.. PubMed. 4(12 Suppl 2). S176–81. 7 indexed citations
13.
Sterling, Timothy R., et al.. (1999). Tuberculosis vaccination versus isoniazid preventive therapy: a decision analysis to determine the preferred strategy of tuberculosis prevention in HIV-infected adults in the developing world.. PubMed. 3(3). 248–54. 7 indexed citations
14.
Clark, Douglas P., et al.. (1998). Cryptosporidiosis in Patients with AIDS: Correlates of Disease and Survival. Clinical Infectious Diseases. 27(3). 536–542. 102 indexed citations
15.
Chaisson, R. E.. (1998). Guidelines for the management of community-acquired pneumonia. PharmacoEconomics & Outcomes News. 161(1). 5–5. 21 indexed citations
16.
Gebo, Kelly A., R. D. Moore, Jeanne Keruly, & R. E. Chaisson. (1996). Risk Factors for Pneumococcal Disease in Human Immunodeficiency Virus-Infected Patients. The Journal of Infectious Diseases. 173(4). 857–862. 78 indexed citations
17.
Chaisson, R. E.. (1995). Tuberculosis and HIV infection. Tuberculosis. 3 indexed citations
18.
Cotton, Deborah, William G. Powderly, Judith Feinberg, et al.. (1993). Guidelines for the Design and Conduct of AIDS Clinical Trials. Clinical Infectious Diseases. 16(6). 816–822. 3 indexed citations
19.
Chaisson, R. E., et al.. (1991). Control of tuberculosis during aerosol therapy administration.. PubMed. 36(9). 1017–25. 1 indexed citations
20.
Chaisson, R. E. & Mark D. Smith. (1990). Pneumocystis carinii pneumonia: diagnosis and management.. PubMed. 39(4). 365–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patricia García de Olalla Breakdown of academic impact, for papers by Andrea Tramarin Breakdown of academic impact, for papers by Helena Huerga Breakdown of academic impact, for papers by Mirjam I. Bakker Breakdown of academic impact, for papers by Frances Wallach Breakdown of academic impact, for papers by Colin Menezes Breakdown of academic impact, for papers by C. Lynn Besch Breakdown of academic impact, for papers by P G Gopi Breakdown of academic impact, for papers by Johann Cailhol Breakdown of academic impact, for papers by Saskia Janssen
Rankless by CCL
2026